Most Read Articles
Yesterday
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
6 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Elvira Manzano, 12 Nov 2019
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Jairia Dela Cruz, 4 days ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.

Aerobic exercise eases dysmenorrhoea-related pain

12 Jul 2019
Are women just over-exaggerating about dysmenorrhoea being labelled "almost as bad as having heart-attack", or is there some truth to it?

Aerobic exercise appears to ease dysmenorrhoea-related pain and improve quality of life (QoL) and daily functioning, a recent study has found.

Researchers randomly assigned 70 women with primary dysmenorrhoea to receive either a 4-week supervised aerobic training regimen or usual care. The primary outcome was pain, while secondary outcomes were quality of life, sleep and daily functioning.

Compared with the control scenario, the exercise regimen yielded significant improvements in pain intensity (visual analogue scale: mean difference, –4.7, 95 percent CI, –9.3 to –0.09) and pain quality (pain rating index: mean difference, –1.9, –3.8 to –0.04). These effects persisted until 4 and 7 months.

Moreover, improvements in present pain achieved statistical significance by 4 months (mean difference, –0.44, –0.72 to –0.16), which persisted until 7 months.

In terms of secondary outcomes, only the change in pain interference achieved statistical significance after 1 month (mean difference, –1.7, –3.4 to –0.02) and likewise persisted until 4 and 7 months.

In comparison, improvements in the physical (mean difference, 4.0, 1.6–6.4) and mental (mean difference, 2.8, 1.0–4.7) component summaries became significant starting month 4. The same was true for pain severity (mean difference, –2.3, –3.9 to –0.78) and percent pain relief (mean difference, 5.1, 2.0–8.3).

On the other hand, the exercise intervention elicited no significant improvements in sleep relative to usual care across all time points.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Yesterday
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
6 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Elvira Manzano, 12 Nov 2019
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Jairia Dela Cruz, 4 days ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.